Clinical drivers for imaging testing in non-metastatic castration-resistant prostate cancer in clinical practice: Results of the IDENTIFICA study.
Sign Up to like & getrecommendations! Published in 2021 at "Actas urologicas espanolas"
DOI: 10.1016/j.acuro.2020.12.001
Abstract: INTRODUCTION The aim of the study was to describe the clinical drivers that lead physicians to perform imaging tests in search of metastasis in non-metastasic castration prostate resistant cancer (nmCRPC) patients. METHODS Observational, cross-sectional study… read more here.
Keywords: prostate; clinical drivers; prostate cancer; study ... See more keywords
Clinical drivers for imaging testing in nonmetastatic castration-resistant prostate cancer: May they be optimized?—Data of “IDENTIFICA” study.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.7_suppl.318
Abstract: 318 Background: Metastases (M+) detection is a critical event in non-metastatic castration-resistant prostate cancer (nmCRPC), as it entails a change in PC management and is a potential surrogate for survival at this stage. PSA doubling… read more here.
Keywords: time; nmcrpc patients; clinical drivers; prostate cancer ... See more keywords